https://regulatorynews.com/city-therapeutics-nasdaq-ipo-rnai-financing Regulatory News en 2026-10-26T10:00:20-04:00 City Therapeutics Closes $230M Nasdaq IPO https://regulatorynews.com/rivanna-boneenhance-fda-clearance Regulatory News en 2026-10-26T10:00:20-04:00 RIVANNA Wins FDA Clearance for BoneEnhance AI https://regulatorynews.com/teleflex-freesolve-rms-coronary-breakthrough-designation Regulatory News en 2026-10-26T10:00:20-04:00 Teleflex's Freesolve Scaffold Wins 2nd Breakthrough Tag https://regulatorynews.com/biocryst-orladeyo-pellets-age-expansion Regulatory News en 2026-10-26T06:08:37-04:00 FDA Extends Orladeyo Pellets to Patients 12 and Up https://regulatorynews.com/fda-olympus-import-alert-gi-expansion Regulatory News en 2026-10-26T06:08:37-04:00 FDA Widens Olympus Import Alert to GI Scopes https://regulatorynews.com/safe-medicines-peptide-compounding-petition Regulatory News en 2026-10-26T06:08:37-04:00 Safety Group Asks FDA to Block Peptide Compounding https://regulatorynews.com/penumbra-lightning-cavt-dvt-physicians Regulatory News en 2026-10-25T10:54:16-04:00 FDA Clears Lightning CAVT for Deep Vein Thrombosis https://regulatorynews.com/ultomiris-iga-nephropathy-physicians Regulatory News en 2026-10-25T10:54:16-04:00 Ultomiris Cleared for IgAN; Kidney Benefit Still Unproven https://regulatorynews.com/nuravax-av1959r-fast-track-designation Regulatory News en 2026-10-25T09:39:40-04:00 Nuravax Wins FDA Fast Track for Alzheimer's Vaccine https://regulatorynews.com/penumbra-lightning-cavt-dvt-clearance Regulatory News en 2026-10-25T09:39:40-04:00 Penumbra's Lightning CAVT Clears FDA for DVT https://regulatorynews.com/astrazeneca-ultomiris-iga-nephropathy-accelerated-approval Regulatory News en 2026-10-25T06:00:16-04:00 FDA Clears First C5 Inhibitor for IgA Kidney Disease https://regulatorynews.com/fda-neuroscience-advancement-innovation-nexus-launch Regulatory News en 2026-10-25T06:00:16-04:00 FDA Launches Neuroscience Hub, Starts on Alzheimer's https://regulatorynews.com/omeros-narsoplimab-chmp-second-rejection Regulatory News en 2026-10-25T06:00:16-04:00 CHMP Rejects Omeros' Narsoplimab for Second Time https://regulatorynews.com/skyrizi-sc-induction-physicians Regulatory News en 2026-10-24T10:49:43-04:00 FDA Approves Subcutaneous-Only Skyrizi Induction